Gallo RC - Search Results

1

Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease.

Harper ME, Kaplan MH, Marselle LM, Pahwa SG, Chayt KJ, Sarngadharan MG, Wong-Staal F, Gallo RC. Harper ME, et al. Among authors: gallo rc. N Engl J Med. 1986 Oct 23;315(17):1073-8. doi: 10.1056/NEJM198610233151707. N Engl J Med. 1986. PMID: 2876381 No abstract available.

2

Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.

Fisher AG, Ratner L, Mitsuya H, Marselle LM, Harper ME, Broder S, Gallo RC, Wong-Staal F. Fisher AG, et al. Among authors: gallo rc. Science. 1986 Aug 8;233(4764):655-9. doi: 10.1126/science.3014663. Science. 1986. PMID: 3014663

3

HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy.

Biberfeld P, Chayt KJ, Marselle LM, Biberfeld G, Gallo RC, Harper ME. Biberfeld P, et al. Among authors: gallo rc. Am J Pathol. 1986 Dec;125(3):436-42. Am J Pathol. 1986. PMID: 3642987 Free PMC article.

4

Kaposi's sarcoma in Zaire is not associated with HTLV-III infection.

Biggar RJ, Melbye M, Kestems L, Sarngadharan MG, de Feyter M, Blattner WA, Gallo RC, Gigase PL. Biggar RJ, et al. Among authors: gallo rc. N Engl J Med. 1984 Oct 18;311(16):1051-2. doi: 10.1056/NEJM198410183111612. N Engl J Med. 1984. PMID: 6090903 No abstract available.

5

Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

Schüpbach J, Haller O, Vogt M, Lüthy R, Joller H, Oelz O, Popovic M, Sarngadharan MG, Gallo RC. Schüpbach J, et al. Among authors: gallo rc. N Engl J Med. 1985 Jan 31;312(5):265-70. doi: 10.1056/NEJM198501313120502. N Engl J Med. 1985. PMID: 2981407

6

Safety of the hepatitis B vaccine.

Stevens CE, Taylor PE, Rubinstein P, Ting RC, Bodner AJ, Sarngadharan MG, Gallo RC. Stevens CE, et al. Among authors: gallo rc. N Engl J Med. 1985 Feb 7;312(6):375-6. doi: 10.1056/NEJM198502073120613. N Engl J Med. 1985. PMID: 2982093 No abstract available.

7

A classification of HTLV-III infection based on 75 cases seen in a suburban community.

Kaplan MH, Pahwa SG, Popovic M, Sarngadharan MG, Gallo RC. Kaplan MH, et al. Among authors: gallo rc. Cancer Res. 1985 Sep;45(9 Suppl):4655s-4658s. Cancer Res. 1985. PMID: 2990703

8

Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome.

Sarngadharan MG, Schüpbach J, Bruch L, Devico A, Markham PD, Wong-Staal F, Gallo RC. Sarngadharan MG, et al. Among authors: gallo rc. Prog Clin Biol Res. 1985;182:309-27. Prog Clin Biol Res. 1985. PMID: 2994105 Review. No abstract available.

9

A human T-lymphotropic retrovirus (HTLV-III) as the cause of the acquired immunodeficiency syndrome.

Gallo RC, Wong-Staal F. Gallo RC, et al. Ann Intern Med. 1985 Nov;103(5):679-89. doi: 10.7326/0003-4819-103-5-679. Ann Intern Med. 1985. PMID: 2996399 Review.

10

Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Harper ME, Marselle LM, Gallo RC, Wong-Staal F. Harper ME, et al. Among authors: gallo rc. Proc Natl Acad Sci U S A. 1986 Feb;83(3):772-6. doi: 10.1073/pnas.83.3.772. Proc Natl Acad Sci U S A. 1986. PMID: 3003749 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

955 results

Search Page